Compound Interest
COVID has generated unprecedented levels of interest in antiviral medicines, but they’re just the latest in a long line of antivirals going back almost 70 years. The latest edition of Periodic Graphics in Chemical & Engineering News looks at some of the key drugs, from the first antiviral to be approved to antivirals for HIV […]
One year ago, in October 2020, the US FDA approved remdesivir: the first antiviral drug approved for COVID-19. While it’s not as effective as was first thought, similar drugs look like they could be more successful. The latest graphic in the #ChemVsCOVID series with the Royal Society of Chemistry examines how they work.